Daré Bioscience, Inc
Price
FilingsNewest: 8-K, Listing noticeOct 2 →InsidersNo open-market buys or sales.→HoldersVanguard 4.2%Geode 0.9%US Bancorp \de\ 0.8%→Financing →PeersClosest companies: BBIO, OCUL, PTCT→
From the filings
Figures
- Revenue
- $1.4Mlast 12 months
- Net income
- −$11.0Mlast 12 months
- Operating cash flow
- −$9.9Mlast 12 months
- Cash and equivalents
- $12.6Mat the last balance sheet
- Total debt
- $10,542at the last balance sheet
- Shares outstanding
- 15.2M shareson issue